Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing to focus on advancing its physics+AI...
Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug discovery and development...
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on December 15, 2025, the company granted restricted stock units (RSUs) with respect to 2,666 shares of the company’s common stock to 6 newly hired...
Schrödinger , Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The live presentation will take place on Wednesday,...
Third Quarter Total Revenue of $54.3 Million, Software Revenue of $40.9 Million Updates 2025 Financial Guidance
Schrödinger (Nasdaq: SDGR) will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the financial markets close. The company will host a conference call and webcast at...
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on October 13, 2025, the company granted restricted stock units (RSUs) with respect to 14,888 shares of the company’s common stock to 10 newly hired...
Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Schrodinger today. The company’s shares opened today at $21.33.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off!...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arvinas Holding Company (ARVN – Research Report) and Schrodinger (SDGR – Research Report) with bullish...
Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Schrodinger today. The company’s shares closed yesterday at $21.21.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55%...